P

Inventor

NUSS JOHN

US15 patents
⚠️ This page may combine multiple inventors who share the name “NUSS JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZOMAGEN BIOSCIENCES LTD

3 patents
US12466800B2Nov 11, 2025

N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS)

ZOMAGEN BIOSCIENCES LTD0 citations47
US12351564B2Jul 8, 2025

NLRP3 modulators

ZOMAGEN BIOSCIENCES LTD0 citations47
US11603375B2Mar 14, 2023

NLRP3 modulators

ZOMAGEN BIOSCIENCES LTD0 citations47

ESCALIER BIOSCIENCES B V

3 patents
US11242350B2Feb 8, 2022

Spirocyclic ROR-gamma modulators

ESCALIER BIOSCIENCES B V0 citations47
US11230555B2Jan 25, 2022

Bicyclic RORγ modulators

ESCALIER BIOSCIENCES B V0 citations47
US10905687B2Feb 2, 2021

Substituted piperazines as ROR-gamma modulators

ESCALIER BIOSCIENCES B V0 citations47

VENTYX BIOSCIENCES INC

2 patents
US11753411B2Sep 12, 2023

Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands

VENTYX BIOSCIENCES INC1 citations57
US11780842B2Oct 10, 2023

TYK2 pseudokinase ligands

VENTYX BIOSCIENCES INC0 citations46

NUSS JOHN

2 patents
US8487117B2Jul 16, 2013

Atropisomers of (hydroxyalkyl) pyrrole derivatives

NUSS JOHN1 citations47
US8642640B2Feb 4, 2014

1-phenylpyrrole derivatives

NUSS JOHN1 citations45

VIMALAN BIOSCIENCES INC

2 patents
US11459333B2Oct 4, 2022

Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors

VIMALAN BIOSCIENCES INC0 citations46
US11136329B2Oct 5, 2021

JAK inhibitors

VIMALAN BIOSCIENCES INC0 citations46

CHEN JEFF

1 patent
US8211929B2Jul 3, 2012

Pyrimidine derivatives as kinase modulators and method of use

CHEN JEFF11 citations79

EXELIXIS INC

1 patent
US7994172B2Aug 9, 2011

[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases

EXELIXIS INC4 citations59

OPPILAN PHARMA LTD

1 patent
US10683291B2Jun 16, 2020

Heterocyclic compounds for the treatment of disease

OPPILAN PHARMA LTD0 citations34